pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
ORKA-001
Plaque Psoriasis (Psoriasis Vulgaris)
$ORKA
Oruka Therapeutics, Inc.
0
catalysts
Phase 2
ORTHO-R
Unspecified Musculoskeletal Disorders
ChitogenX Inc
0
catalysts
Phase 2
ORX-142
Sleep Disorders
$CNTA
Centessa Pharmaceuticals plc
0
catalysts
Phase 2
OTL-201
← prev
page 21 of 50
next →
131
Pain
89
Neurology
1
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Kyowa Kirin Co Ltd
0
catalysts
Phase 2
OXI-4503
Refractory Acute Myeloid Leukemia
$OTLC
Oncotelic Therapeutics, Inc.
0
catalysts
Phase 2
OpRegen
Geographic Atrophy
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 2
Optiquel
Non-infectious Uveitis
Enzo Biochem Inc
0
catalysts
Phase 2
Organ Dysfunction/Mortality
Unspecified
BioAegis Therapeutics Inc
0
catalysts
Phase 2
OriCAR-017
Refractory Multiple Myeloma
Oricell Therapeutics (Shanghai) Co Ltd
0
catalysts
Phase 2
P-12
Burns
Penicillin-binding protein
NeoMatrix Therapeutics Inc
0
catalysts
Phase 2
P-4M01
Periodontal Disease
P4 Microbiome Inc
0
catalysts
Phase 2
PALI-2108
Ulcerative Colitis
$PALI
PALISADE BIO, INC.
0
catalysts
Phase 2
PAX-1
Bile Duct Cancer (Cholangiocarcinoma)
Komipharm International Co Ltd
0
catalysts
Phase 2
PBF-999
Prader-Willi Syndrome (PWS)
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Adenosine receptor A2a
Palobiofarma SL
0
catalysts
Phase 2
PBFT-02
Frontotemporal Dementia (Pick Disease)
$PASG
Passage BIO, Inc.
0
catalysts
Phase 2
PBGENE-HBV
Hepatitis B
$DTIL
PRECISION BIOSCIENCES INC
0
catalysts
Phase 2
PBGM-01
GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency)
GEMMA Biotherapeutics Inc
0
catalysts
Phase 2
PBI-05204
Metastatic Adenocarcinoma of The Pancreas
Phoenix Biotechnology Inc
0
catalysts
Phase 2
PEEL-224
Neuroblastoma
Peel Therapeutics Inc
0
catalysts
Phase 2
PER-001
Diabetic Retinopathy
Perfuse Therapeutics Inc
0
catalysts
Phase 2
PF-07868489
Pulmonary Arterial Hypertension
$PFE
PFIZER INC
0
catalysts
Phase 2
PF-07872412
Streptococcal Pneumonia
$PFE
PFIZER INC
0
catalysts
Phase 2
PFL-002
Non-Small Cell Lung Cancer
Pierre Fabre Pharmaceuticals Inc
0
catalysts
Phase 2
PFL-241
Non-Small Cell Lung Cancer
Laboratoires Pierre Fabre SA
0
catalysts
Phase 2
PFL-721
Non-Small Cell Lung Cancer
Laboratoires Pierre Fabre SA
0
catalysts
Phase 2
PH-10
Xantryl
Atopic Dermatitis (Atopic Eczema)
$PVCT
PROVECTUS BIOPHARMACEUTICALS, INC.
0
catalysts
Phase 2
PH-15
Cognitive Impairment
$VTGN
Vistagen Therapeutics, Inc.
0
catalysts
Phase 2
PHN-031
Osteoporosis
PhytoHealth Corp
0
catalysts
Phase 2
PHN-033
Diabetic Nephropathy
PhytoHealth Corp
0
catalysts
Phase 2
PKN-605
Atrial Fibrillation
$NVS
NOVARTIS AG
0
catalysts
